Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma

被引:70
作者
Ugolini, Clara
Basolo, Fulvio
Proietti, Agnese
Vitti, Paolo
Elisei, Rossella
Miccoli, Paolo
Toniolo, Antonio
机构
[1] Univ Pisa, Dept Surg, Div Pathol, I-56126 Pisa, Italy
[2] Univ Pisa, Dept Endocrinol, I-56126 Pisa, Italy
[3] Univ Pisa, Dept Surg, Div Endocrine Surg, I-56126 Pisa, Italy
[4] Univ Insubria, Lab Med Microbiol, Varese, Italy
关键词
D O I
10.1089/thy.2006.0306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Numerous studies indicate that papillary thyroid carcinomas (PTC) with lymphocytic infiltrates are associated with a less extensive disease at diagnosis and improved disease-free survival. The infiltration of lymphocytes and immature CD1a+ dendritic cells (DC) was characterized in papillary, poorly differentiated (PDC), and undifferentiated (UC) carcinomas to evaluate their association with immunological infiltrates. Design: A series of 527 consecutive cases of thyroid carcinoma treated by total thyroidectomy were investigated by histopathological and immunohistochemical methods. The inflammatory infiltrate was quantified and typed in intratumoral and peritumoral tissues as well as in the controlateral lobe. Main outcome: The intratumoral infiltrate was strongly reduced or absent in PDC and UC. Intense infiltrates were detected in the PTC tall cell variant. In all histotypes, the extent of the intratumoral and peritumoral infiltrates was comparable. Immature DC were detected in PTCs and markedly reduced in PDC and UC. CD1a+ DCs were detected in a small percentage of PDC and UC. Conclusions: Though a relationship between the extent of lymphocyte/DC infiltrates and the prognosis of PTCs could not be demonstrated, tumors with poor prognosis (PDCs, UCs) were characterized by markedly reduced lymphocyte/DC infiltrates. The study appears to confirm the protective role of DC and infiltrating lymphocytes against thyroid tumors.
引用
收藏
页码:389 / 393
页数:5
相关论文
共 16 条
[1]  
BACHLEITNERHOFM.T, 2006, J CLIN ENDOCR METAB, V87, P1098
[2]   S-100 protein+ dendritic cells and CD34+ dendritic interstitial cells in thyroid lesions [J].
Batistatou, A ;
Zolota, V ;
Scopa, CD .
ENDOCRINE PATHOLOGY, 2002, 13 (02) :111-115
[3]   CD1a in human cancers: a new role for an old molecule [J].
Coventry, B ;
Heinzel, S .
TRENDS IN IMMUNOLOGY, 2004, 25 (05) :242-248
[4]   Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells [J].
Dadabayev, AR ;
Sandel, MH ;
Menon, AG ;
Morreau, H ;
Melief, CJM ;
Offringa, R ;
van der Burg, SH ;
Janssen-van Rhijn, C ;
Ensink, NG ;
Tollenaar, RAEM ;
van de Velde, CJH ;
Kuppen, PJK .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (11) :978-986
[5]   Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults [J].
Gupta, S ;
Patel, A ;
Folstad, A ;
Fenton, C ;
Dinauer, CA ;
Tuttle, RM ;
Conran, R ;
Francis, GL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1346-1354
[6]   Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome [J].
Haq, M ;
Harmer, C .
CLINICAL ENDOCRINOLOGY, 2005, 63 (01) :87-93
[7]   THE CORRELATION BETWEEN PAPILLARY THYROID-CARCINOMA AND LYMPHOCYTIC INFILTRATION IN THE THYROID-GLAND [J].
MATSUBAYASHI, S ;
KAWAI, K ;
MATSUMOTO, Y ;
MUKUTA, T ;
MORITA, T ;
HIRAI, K ;
MATSUZUKA, F ;
KAKUDOH, KI ;
KUMA, K ;
TAMAI, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3421-3424
[8]   Breaking tolerance to tumors with dendritic cell-based immunotherapy [J].
Mende, I ;
Engleman, EG .
THERAPEUTIC OLIGONUCLEOTIDES: TRANSCRIPTIONAL AND TRANSLATIONAL STRATEGIES FOR SILENCING GENE EXPRESSION, 2005, 1058 :96-104
[9]   Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes [J].
Modi, J ;
Patel, A ;
Terrell, R ;
Tuttle, RM ;
Francis, GL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) :4418-4425
[10]   Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies [J].
Schott, M ;
Seissler, J .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (04) :156-162